Skip to content

Study · Not a test of the peptide alone · 1989

3 results

[The effect of thymalin on indices of immunity and hemostasis in patients with disseminated forms of psoriasis].

Isaeva MP, Budazhabon GB, Kuznik BI

Vestnik dermatologii i venerologii1 Jan 1989

PMID2609748 (opens in a new tab)PepBankPUB-02609748
Publisher pageAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone3

In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymalin.

  1. 01HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In psoriasis patients, combined therapy with thymalin completely or incompletely normalized immunity parameters.

    In plain wordsIn psoriasis patients, combined therapy with thymalin completely or partly normalized immune measures.

    Peptide
    Thymalin
    Outcome
    Not applicableImmunity parameters
    Study

    n: not reported in source

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    Use of thymalin in combined therapy of psoriasis patients has resulted in normalization (complete or incomplete) of the immunity and hemostasis parameters; this has been parallelled by improvement of the clinical status of the patients.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  2. 02HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In psoriasis patients, combined therapy with thymalin completely or incompletely normalized hemostasis parameters.

    In plain wordsIn psoriasis patients, combined therapy with thymalin completely or partly normalized blood clotting measures.

    Peptide
    Thymalin
    Outcome
    Not applicableHemostasis parameters
    Study

    n: not reported in source

    Outcome group
    Bleeding and clotting · Cardiovascular

    Source sentences

    Summary
    Use of thymalin in combined therapy of psoriasis patients has resulted in normalization (complete or incomplete) of the immunity and hemostasis parameters; this has been parallelled by improvement of the clinical status of the patients.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  3. 03HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In psoriasis patients, combined therapy with thymalin was accompanied by improved clinical status.

    In plain wordsIn psoriasis patients, clinical condition improved alongside combined therapy that included thymalin.

    Peptide
    Thymalin
    Outcome
    IncreaseClinical status
    Study

    n: not reported in source

    Outcome group
    Skin and hair · Skin and wound

    Source sentences

    Summary
    Use of thymalin in combined therapy of psoriasis patients has resulted in normalization (complete or incomplete) of the immunity and hemostasis parameters; this has been parallelled by improvement of the clinical status of the patients.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.